Anatara Lifesciences Ltd (ANR.AX)
AUD 0.05
(0.0%)
AUD 0.05
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -1.45 Million AUD | 54.64% |
| 2023 | -3.21 Million AUD | -8.76% |
| 2022 | -2.97 Million AUD | 3.51% |
| 2021 | -3.01 Million AUD | 25.86% |
| 2020 | -4 Million AUD | -40.22% |
| 2019 | -3.68 Million AUD | 20.7% |
| 2018 | -4.71 Million AUD | -97.72% |
| 2017 | -4.21 Million AUD | -92.34% |
| 2016 | -1.22 Million AUD | 50.39% |
| 2015 | - AUD | -16159.78% |
| 2014 | 12.43 Thousand AUD | 1234.55% |
| 2013 | 932.00 AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 FY | - AUD | 35.56% |
| 2024 Q4 | -775.56 Thousand AUD | 0.0% |
| 2024 Q2 | -953.85 Thousand AUD | 0.0% |
| 2023 FY | - AUD | -8.76% |
| 2023 Q4 | -1.92 Million AUD | 0.0% |
| 2023 Q2 | -1.33 Million AUD | 0.0% |
| 2022 Q2 | -1.5 Million AUD | 0.0% |
| 2022 FY | - AUD | 3.51% |
| 2022 Q4 | -1.49 Million AUD | 0.0% |
| 2021 Q4 | -1.39 Million AUD | 0.0% |
| 2021 Q2 | -1.71 Million AUD | 0.0% |
| 2021 FY | - AUD | 25.86% |
| 2020 Q2 | -2.24 Million AUD | 0.0% |
| 2020 FY | - AUD | -40.22% |
| 2020 Q4 | -1.94 Million AUD | 0.0% |
| 2019 FY | - AUD | 20.7% |
| 2019 Q4 | -1.32 Million AUD | 0.0% |
| 2019 Q2 | -2.07 Million AUD | 0.0% |
| 2018 FY | - AUD | -97.72% |
| 2018 Q4 | -1.99 Million AUD | 0.0% |
| 2018 Q2 | -1.77 Million AUD | 0.0% |
| 2017 Q2 | -506.73 Thousand AUD | 0.0% |
| 2017 FY | - AUD | -92.34% |
| 2017 Q4 | -1.39 Million AUD | 0.0% |
| 2016 Q2 | 105.83 Thousand AUD | 0.0% |
| 2016 FY | - AUD | 50.39% |
| 2016 Q4 | -990.86 Thousand AUD | 0.0% |
| 2015 Q2 | 47.98 Thousand AUD | 0.0% |
| 2015 FY | - AUD | -16159.78% |
| 2015 Q4 | -46.31 Thousand AUD | 0.0% |
| 2014 Q3 | - AUD | -100.0% |
| 2014 Q2 | 468.00 AUD | 0.0% |
| 2014 FY | - AUD | 1234.55% |
| 2014 Q4 | 11.97 Thousand AUD | 0.0% |
| 2013 FY | - AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 10.37 Million AUD | 114.04% |
| Zelira Therapeutics Limited | -36.44 Million AUD | 96.003% |
| Biome Australia Limited | -1.57 Million AUD | 7.704% |
| Patrys Limited | -3.49 Million AUD | 58.288% |
| Orthocell Limited | -11.68 Million AUD | 87.53% |
| Imugene Limited | -147.97 Million AUD | 99.016% |
| Noxopharm Limited | -5.94 Million AUD | 75.5% |
| PYC Therapeutics Limited | -38.11 Million AUD | 96.178% |
| Chimeric Therapeutics Limited | -11.29 Million AUD | 87.109% |
| Prescient Therapeutics Limited | -7.18 Million AUD | 79.728% |
| Proteomics International Laboratories Limited | -7.88 Million AUD | 81.532% |
| Cynata Therapeutics Limited | -9.95 Million AUD | 85.36% |
| CSL Limited | 4.73 Billion AUD | 100.031% |
| Arovella Therapeutics Limited | -8.83 Million AUD | 83.509% |
| Bio-Gene Technology Limited | -2.97 Million AUD | 51.036% |
| Clinuvel Pharmaceuticals Limited | 51.86 Million AUD | 102.809% |
| Starpharma Holdings Limited | -12.57 Million AUD | 88.418% |
| Nanollose Limited | -1.14 Million AUD | -26.898% |
| Memphasys Limited | -3.3 Million AUD | 55.962% |
| Invex Therapeutics Ltd | -720.44 Thousand AUD | -102.191% |
| NeuroScientific Biopharmaceuticals Limited | -1.79 Million AUD | 18.907% |
| Amplia Therapeutics Limited | -4.55 Million AUD | 68.053% |
| Botanix Pharmaceuticals Limited | -13.91 Million AUD | 89.535% |
| Island Pharmaceuticals Limited | -2.81 Million AUD | 48.311% |
| Race Oncology Limited | -14.2 Million AUD | 89.744% |
| Nyrada Inc. | -4.59 Million AUD | 68.307% |
| Telix Pharmaceuticals Limited | 22.96 Million AUD | 106.343% |
| Dimerix Limited | -24.95 Million AUD | 94.164% |
| PharmAust Limited | -9.45 Million AUD | 84.588% |
| Immutep Limited | -42.87 Million AUD | 96.603% |
| Clarity Pharmaceuticals Ltd | -44.64 Million AUD | 96.737% |
| Alterity Therapeutics Limited | -19.57 Million AUD | 92.557% |
| BTC Health Limited | 1.05 Million AUD | 238.035% |
| Acrux Limited | -7.93 Million AUD | 81.633% |
| Neuren Pharmaceuticals Limited | 199.26 Million AUD | 100.731% |
| Biotron Limited | -5.04 Million AUD | 71.098% |
| Tissue Repair Ltd | -5.77 Million AUD | 74.776% |
| AdAlta Limited | -5.3 Million AUD | 72.53% |
| Radiopharm Theranostics Limited | -45.37 Million AUD | 96.79% |
| Hexima Limited | -995.54 Thousand AUD | -46.319% |
| AnteoTech Limited | -11.57 Million AUD | 87.411% |
| Paradigm Biopharmaceuticals Limited | -64.53 Million AUD | 97.743% |
| Recce Pharmaceuticals Ltd | -21.35 Million AUD | 93.179% |
| Avecho Biotechnology Limited | -3.24 Million AUD | 55.076% |
| Actinogen Medical Limited | -12.92 Million AUD | 88.727% |
| Immuron Limited | -6.19 Million AUD | 76.476% |
| Argenica Therapeutics Limited | -1.89 Million AUD | 23.236% |